Sabby Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,315	Closed	-$861K	–	184
2018 Q1	$861K	Buy	1,315 +396	+43%	+$64.7K	0.1%	73
2017 Q4	$13.8M	Sell	919 -1,946	-68%	-$288K	1.25%	15
2017 Q3	$43.6M	Sell	2,865 -1,688	-37%	-$254K	2.85%	10
2017 Q2	$58.7M	Buy	4,553 +3,177	+231%	+$382K	3.84%	7
2017 Q1	$15M	Buy	1,376 +306	+29%	+$26.9K	0.81%	21
2016 Q4	$7.88M	Sell	1,070 -885	-45%	-$72K	0.46%	36
2016 Q3	$17.1M	Buy	1,955 +1,346	+221%	+$127K	0.64%	30
2016 Q2	$5.24M	Buy	609 +59	+11%	+$5.1K	0.27%	55
2016 Q1	$4.37M	Buy	550 +209	+61%	+$18.9K	0.22%	48
2015 Q4	$4.29M	Hold	341	–	–	0.24%	69
2015 Q3	$3.55M	Buy	341 +206	+153%	+$26.5K	0.15%	107
2015 Q2	$1.67M	Sell	135 -99	-42%	-$12.5K	0.06%	184
2015 Q1	$2.76M	Sell	234 -3,647	-94%	-$437K	0.11%	118
2014 Q4	$46.1K	Sell	3,881 -18,788	-83%	-$2.12M	1.46%	13
2014 Q3	$255K	Sell	22,669 -7,167	-24%	-$682K	9.78%	3
2014 Q2	$282M	Buy	29,836 +5,836	+24%	+$409K	12.11%	2
2014 Q1	$170M	Sell	24,000 -2,661	-10%	-$211K	9.52%	1
2013 Q4	$198M	Buy	26,661 +1,771	+7%	+$123K	12.63%	1
2013 Q3	$189M	Buy	24,890 +1,825	+8%	+$145K	12.26%	1
2013 Q2	$184M	Buy	+23,065	New	+$1.7M	12.3%	1